Date: 2012-12-20
Type of information: Company acquisition
Acquired company: Dosch Pharmaceuticals (India)
Acquiring company: Merial, a Sanofi company (France)
Amount: Financial details were not disclosed.
Terms: Merial, the animal health division of Sanofi has announced that Sanofi has entered into a binding agreement to acquire the animal health division of the Indian company Dosch Pharmaceuticals Private Limited, creating a market entry for Merial in that country’s strategically important and growing animal health sector. The agreement is subject to regulatory approval and is expected to finalize sometime in the first half of 2013.
Dosch CEO, Dr. Sharat Tugnait and his management team will manage the future combined operations of Dosch and Merial in India under the supervision of Mayank Parekh, Merial.
Details: Dosch Pharmaceuticals, headquartered in Mumbai, India, is a diversified pharmaceutical company, primarily operating through two divisions, animal health and exports. The animal health division being acquired by Merial has more than 86 products under 50 brands for ruminants, poultry and companion animals. Products include an extensive range of animal health therapeutics and nutritional feed supplements. Within the animal health division, Dosch has a 279 member sales force, covering 18 Indian states.
The animal health market in India is estimated at more than €350 million* in 2012, and is experiencing annual double digit growth. India is home to the world’s largest herd of cattle and buffalo, second largest herd of sheep and goats, and has the world’s fifth largest population of poultry. India is also the world’s largest milk producer.
Related: Veterinary medicine
